Fox Run Management, L.L.C. Jazz Pharmaceuticals PLC Transaction History

Fox Run Management, L.L.C.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$103.94 - $118.98 $872,368 - $998,599	8,393 Added 191.93%	12,766 $1.36 Million
Q1 2024 May 13, 2024	SELL	$115.19 - $132.77 $238,212 - $274,568	-2,068 Reduced 32.11%	4,373 $526,000
Q4 2023 Feb 13, 2024	BUY	$114.26 - $136.0 $735,948 - $875,976	6,441 New	6,441 $792,000
Q2 2023 Aug 11, 2023	BUY	$122.5 - $147.16 $57,697 - $69,312	471 Added 13.53%	3,953 $490,000
Q1 2023 May 12, 2023	BUY	$133.98 - $160.47 $466,518 - $558,756	3,482 New	3,482 $509,000
Q1 2020 May 08, 2020	SELL	$87.74 - $152.74 $121,783 - $212,003	-1,388 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$117.65 - $153.73 $163,298 - $213,377	1,388 New	1,388 $207,000
Q1 2019 Oct 17, 2019	SELL	$121.81 - $142.95 $215,725 - $253,164	-1,771 Closed	0 $0
Q4 2018 Jan 15, 2019	BUY	$115.94 - $166.74 $205,329 - $295,296	1,771 New	1,771 $220,000
Q1 2018 Apr 17, 2018	SELL	$135.59 - $157.16 $254,095 - $294,517	-1,874 Closed	0 $0
Q4 2017 Jan 18, 2018	BUY	$131.06 - $150.39 $9,698 - $11,128	74 Added 4.11%	1,874 $252,000
Q3 2017 Oct 23, 2017	BUY	$142.62 - $155.6 $256,716 - $280,080	1,800	1,800 $263,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.